436
Vol. 56, No. 4
150 °C (AcOEt–hexane), IR (Nujol) cmꢂ1: 1725, 2570 (br); 1H-NMR 365.1353. Found: 365.1352.
(500 MHz, CDCl3ꢁDMSO-d6) d: 3.11ꢁ3.03 (s, 3H), 3.92ꢁ4.22 (s, 2H),
3-(4-Bromophenyl)-6-trifluoromethyl-1,4,5,6-tetrahydro-4-methyl-1-
7.31ꢁ7.37 (d, 2H, Jꢀ8.2), 7.53ꢁ7.56 (d, 2H, Jꢀ8.2); MS m/z: 271 (1.8)ꢁ phenyl-1,2,4-triazin-6-ol (3c) Oil, IR (oil) cmꢂ1: 1610, 3250 (br); 1H-
273 (1.8) (Mꢁ, 1 : 1), 183 (100)ꢁ185 (98). Anal. Calcd for C10H10BrNO3: C,
44.14; H, 3.70; N, 5.15. Found: C, 44.22; H, 3.58; N, 4.86.
NMR (500 MHz, CDCl3) d: 2.89 (s, 3H), 3.52 (d, 1H, Jꢀ12.8), 3.76 (d, 1H,
Jꢀ12.8), 7.15 (t, 1H, Jꢀ7.8), 7.28 (t, 2H, Jꢀ7.8), 7.38 (d, 2H, Jꢀ8.5), 7.40
(d, 2H, Jꢀ7.8), 7.51 (d, 2H, Jꢀ8.5); 13C-NMR (125 MHz, CDCl3) d: 40.48
(CH3), 52.40 (CH2), 79.52 (C, 2JCFꢀ30), 123.38 (CF3, 1JCFꢀ290), 123.93
N-Acetyl-N-phenylglycine (2d) mp 196—198 °C (mp11) 193—195 °C).
N-Benzyl-N-(4-methoxybenzoyl)glycine (2e) Yield 84%, mp 149—
1
151 °C (AcOEt–hexane), IR (Nujol) cmꢂ1: 1590, 1740, 2700 (br); H-NMR (C), 125.59 (CH), 125.79 (CH), 128.68 (CH), 130.13 (CH), 131.63 (CH),
(500 MHz, CDCl3) d: 3.82 (s, 2H), 4.17 (s, 2H), 4.71 (s, 2H), 6.89 (d, 2H, 132.89 (C), 144.04 (C), 147.04 (C); MS m/z: 413 (100)ꢁ415 (100) (Mꢁ,
Jꢀ8.2), 7.19—7.42 (m, 5H), 7.47—7.56 (br, 2H); MS m/z: 299 (Mꢁ, 10), 1 : 1). HR-MS Calcd for C17H1579BrF3N3O (C17H1581BrF3N3O): 413.0323
135 (100). Anal. Calcd for C17H17NO4: C, 68.22; H, 5.72; N, 4.68. Found: C, (415.0336). Found: 413.0337 (415.0333).
68.20; H, 5.91; N, 4.64.
6-Trifluoromethyl-1,4,5,6-tetrahydro-3-methyl-1,4-diphenyl-1,2,4-tri-
N-Phenyl-N-(4-methoxybenzoyl)glycine (2f) Yield 88%, mp 135—
azin-6-ol (3d) mp 139—141 °C (Et2O–hexane), IR (Nujol) cmꢂ1: 1630,
137 °C (AcOEt–hexane) (lit.27) mp 158—163 °C), IR (Nujol) cmꢂ1: 1660, 3000 (br); 1H-NMR (500 MHz, CDCl3) d: 1.86 (s, 3H), 3.46 (dq, 1H, Jꢀ1.5,
1
1730, 3070 (br); H-NMR (500 MHz, CDCl3) d: 3.74 (s, 3H), 4.62 (s, 2H),
6.66 (d, 2H, Jꢀ7.7), 7.25 (t, 2H, Jꢀ7.7), 7.31 (d, 2H, Jꢀ8.9).
11.9), 3.90 (d, 1H, Jꢀ11.9), 7.11 (d, 2H, Jꢀ7.7), 7.17 (t, 1H, Jꢀ7.7), 7.26
(t, 1H, Jꢀ7.7), 7.33 (t, 2H, Jꢀ7.7), 7.38 (t, 2H, Jꢀ7.7), 7.45 (d, 2H, Jꢀ7.7);
13C-NMR (125 MHz, CDCl3) d: 19.29 (CH3), 52.09 (CH2), 80.16 (C,
N-Methyl-N-pivaloylglycine (2g) mp 75—76 °C (mp17) 75—76 °C).
General Procedure for the Preparation of 1 TFAA (11 ml, 78 mmol) 2JCFꢀ30), 123.30 (CF3, 1JCFꢀ290), 125.47 (CH), 125.69 (CH), 125.98
was added to a stirred solution of N-acyl-N-alkylglycine (26 mmol) in (CH), 126.49 (CH), 128.68 (CH), 129.36 (CH), 141.49 (C), 143.64 (C),
CH2CH2 (50 ml) at 0 °C for 10 min. The mixture was stirred at 25 °C for 3 h
and then extracted with CH2Cl2 (80 mlꢃ2). The combined extracts were 60.89; H, 4.81; N, 12.53. Found: C, 60.67; H, 4.89; N, 12.46.
washed successively with 3% HCl, H2O, 1% Na2CO3, and H2O. After the
6-Trifluoromethyl-1,4,5,6-tetrahydro-3-(4-methoxyphenyl)-1-phenyl-
144.65 (C); MS m/z: 335 (Mꢁ, 100). Anal. Calcd for C17H16F3N3O: C,
standard workup, the residue was recrystallized from CH2Cl2–hexane to give 4-phenylmethy-1,2,4-triazin-6-ol (3e) Oil, IR (oil) cmꢂ1: 1610, 1740,
the 4-trifluoroacetyl-1,3-oxazolium-5-olates (1).
3300 (br); 1H-NMR (500 MHz, CDCl3) d: 3.45 (d, 1H, Jꢀ13.0), 3.69 (d, 1H,
Jꢀ13.0), 3.79 (s, 3H), 4.36 (d, 1H, Jꢀ16.0), 4.48 (d, 1H, Jꢀ16.0), 6.88
(d, 2H, Jꢀ8.8), 7.26—7.43 (m, 10H), 7.52 (d, 2H, Jꢀ8.8); 13C-NMR
(125 MHz, CDCl3) d: 49.59 (CH2), 55.33 (CH3), 55.64 (CH2), 79.61 (C,
4-Trifluoroacetyl-3-methyl-2-phenyl-1,3-oxazolium-5-olate (1a) mp
161—163 °C (mp17) 162—163 °C).
2-(4-Bromophenyl)-4-trifluoroacetyl-3-methyl-1,3-oxazolium-5-olate
(1b) mp 75—76 °C (mp17) 75—76 °C).
1
2JCFꢀ30), 114.06 (CH), 123.79 (CF3, JCFꢀ279), 126.15 (CH), 126.23 (C),
2-(4-Bromophenyl)-4-trifluoroacetyl-3-methyl-1,3-oxazolium-5-olate
127.25 (CH), 127.84 (CH), 128.57 (CH), 128.85 (CH), 128.97 (CH), 129.27
(1c) Yield 89%, mp 188—191 °C (CH2Cl2–hexane), IR (Nujol) cmꢂ1
:
(C), 129.82 (CH), 137.23 (C), 144.34 (C), 160.89 (C); MS m/z: 441 (Mꢁ,
1780; 1H-NMR (500 MHz, CDCl3) d: 4.14 (s, 3H), 7.62 (d, 2H, Jꢀ8.9), 7.80 47), 332 (100). HR-MS Calcd for C24H22F3N3O2: 441.1664. Found:
(d, 2H, Jꢀ8.9); MS m/z: 349 (23)ꢁ351 (22) (Mꢁ, 1 : 1), 183 (100)ꢁ185 441.1653.
(99). Anal. Calcd for C12H7BrF3NO3: C, 41.17; H, 2.02; N, 4.00. Found: C,
40.99; H, 2.10; N, 3.80.
6-Trifluoromethyl-1,4,5,6-tetrahydro-3-(4-methoxyphenyl)-1,4-diphenyl-
1,2,4-triazin-6-ol (3f) mp 129—131 °C (Et2O–hexane), IR (Nujol) cmꢂ1
:
2-(4-Bromophenyl)-4-trifluoroacetyl-3-methyl-1,3-oxazolium-5-olate
1620, 3200 (br); 1H-NMR (500 MHz, CDCl3) d: 3.49 (dq, 1H, Jꢀ2.1, 12.8),
3.73 (s, 3H), 4.19 (d, 1H, Jꢀ12.8), 6.82—6.76 (m, 2H), 6.78 (d, 2H, Jꢀ7.6),
6.95—6.99 (m, 1H), 7.13—7.20 (m, 3H), 7.31—7.38 (m, 4H), 7.51 (d, 2H,
(1d) mp 75—76 °C (mp17) 75—76 °C).
3-Benzyl-4-trifluoroacetyl-2-(4-methoxyphenyl)-1,3-oxazolium-5-
olates (1e) mp 158—160 °C (AcOEt–hexane), IR (Nujol) cmꢂ1: 1780; 1H- Jꢀ7.6); 13C-NMR (125 MHz, CDCl3) d: 51.72 (CH2), 55.17 (CH3), 81.18
2
1
NMR (500 MHz, CDCl3) d: 3.89 (s, 3H), 5.78 (s, 2H), 7.02 (d, 2H, Jꢀ9.0),
(C, JCFꢀ30), 113.48 (CH), 123.07 (CH), 123.31 (CF3, JCFꢀ290), 123.66
7.18 (d, 2H, Jꢀ7.2), 7.37 (t, 1H, Jꢀ7.2), 7.41 (t, 2H, Jꢀ7.2), 7.65 (d, 2H, (CH), 124.25 (CH), 124.71 (CH), 125.56 (C), 128.71 (CH), 128.76 (CH),
Jꢀ9.0); MS m/z: 377 (Mꢁ, 4), 91 (100). Anal. Calcd for C19H14F3NO4: C,
60.48; H, 3.74; N, 3.71. Found: C, 60.20; H, 3.86; N, 3.64.
129.91 (CH), 142.20 (C), 144.11 (C), 144.61 (C), 160.09 (C); MS m/z: 427
(Mꢁ, 100). HR-MS Calcd for C23H20F3N3O2: 427.1507. Found: 427.1491.
6-Trifluoromethyl-1,4,5,6-tetrahydro-4-methyl-3-phenyl-1,2,4-triazin-
6-ol (3g) The procedure was the same as described above, except that
4-Trifluoroacetyl-2-(4-methoxyphenyl)-3-phenyl-1,3-oxazolium-5-
olates (1f) mp 182—185 °C (AcOEt–hexane), IR (Nujol) cmꢂ1: 1790; 1H-
NMR (60 MHz, CDCl3) d: 3.80 (s, 3H), 6.75 (d, 2H, Jꢀ9.0), 7.58 (d, 2H, phenylhydrazine was replaced with hydrazine: Yield 45%, mp 159—161 °C
Jꢀ9.0), 7.07—7.63 (m, 5H); MS m/z: 363 (Mꢁ, 19), 135 (100). Anal. Calcd (Et2O), IR (Nujol) cmꢂ1: 1620, 3000 (br), 3310; 1H-NMR (500 MHz,
for C18H12F3NO4: C, 59.51; H, 3.33; N, 3.86. Found: C, 59.38; H, 3.49; N, CDCl3ꢁDMSO-d6, 5 : 1) d: 2.76 (s, 3H), 3.35 (dd, 1H, Jꢀ2.5, 11.6), 3.60
4.02.
3-tert-Butyl-4-trifluoroacetyl-2-methyl-1,3-oxazolium-5-olate (1g) mp
120—121 °C (mp17) 120—121 °C).
(d, 1H, Jꢀ11.6), 5.53 (s, 1H), 6.63 (s, 1H), 7.36—7.37 (m, 3H), 7.42—7.44
(m, 2H); 13C-NMR (125 MHz, CDCl3ꢁDMSO-d6, 5 : 1) d: 40.28 (CH3),
51.55 (CH2), 77.42 (C, 2JCFꢀ30), 123.69 (CF3, 1JCFꢀ287), 128.11 (CH),
General Procedure for the Reaction of 1 with PH in DMF Phenylhy- 128.26 (CH), 128.76 (CH), 134.40 (C), 148.54 (C); MS m/z: 259 (Mꢁ, 25),
drazine (162 mg, 1.5 mmol) was added to a solution of 1 (1 mmol) in dry
DMF (5 ml) at 0 °C and the mixture was stirred at rt for 24 h. The mixture
was diluted with AcOEt (30 ml) and washed with 3% Na2CO3 (20 ml), fol-
241 (100). Anal. Calcd for C11H12F3N3O: C, 50.97; H, 4.67; N, 16.21.
Found: C, 51.01; H, 4.77; N, 16.13.
6-Trifluoromethyl-1,4,5,6-tetrahydro-1,4-dimethyl-3-phenyl-1,2,4-tri-
lowed by brine (20 ml). After the standard work-up, the residue was purified azin-6-ol (3h) The procedure was the same as described above, except that
by chromatography on silica gel with AcOEt–hexane (2 : 3).
phenylhydrazine was replaced with methylhydrazine: Yield 58%, mp 153—
6-Trifluoromethyl-1,4,5,6-tetrahydro-4-methyl-1,3-diphenyl-1,2,4-tri- 154 °C (Et2O–hexane), IR (Nujol) cmꢂ1
1610, 3000 (br); 1H-NMR
:
azin-6-ol (3a) Oil, IR (oil) cmꢂ1: 1640, 3250 (br); 1H-NMR (500 MHz,
(500 MHz, CDCl3) d: 2.76 (s, 3H), 2.87ꢁ2.88 (s, 3H), 3.27 (dd, 1H, Jꢀ1.3,
CDCl3) d: 2.88 (s, 3H), 3.48 (dq, 1H, Jꢀ2.1, 12.8), 3.73 (d, 1H, Jꢀ12.8), 11.9), 3.54 (d, 1H, Jꢀ11.9), 7.36—7.39 (m, 3H), 7.41—7.44 (m, 2H); 13C-
7.13—7.18 (m, 1H), 7.27—7.32 (m, 2H), 7.36—7.39 (m, 4H), 7.40—7.44 NMR (125 MHz, CDCl3) d: 38.32ꢁ38.33 (CH3), 39.94 (CH3), 53.52 (CH2),
(m, 1H), 7.48—7.51 (m, 2H); 13C-NMR (125 MHz, CDCl3) d: 40.47 (CH3),
79.67 (C, 2JCFꢀ30), 123.50 (CF3, 1JCFꢀ290), 128.44 (CH), 128.56 (CH),
52.41 (CH2), 79.27 (C, 2JCFꢀ30), 123.49 (CF3, 1JCFꢀ291), 125.56 (CH), 129.18 (CH), 133.63 (C), 148.23 (C); MS m/z: 273 (Mꢁ, 68), 255 (100).
125.69 (CH), 128.32 (CH), 128.57 (CH), 128.71 (CH), 129.16 (CH), 133.82 Anal. Calcd for C12H14F3N3O: C, 52.75; H, 5.16; N, 15.38. Found: C, 53.01;
(C), 144.58 (C), 147.11 (C); MS m/z: 335 (Mꢁ, 47), 77 (100). HR-MS Calcd
for C17H16F3N3O: 335.1245. Found: 335.1215.
6-Trifluoromethyl-1,4,5,6-tetrahydro-3-(4-methoxyphenyl)-4-methyl-
H, 5.25; N, 15.36.
6-Trifluoromethyl-1,4,5,6-tetrahydro-3-(4-methoxyphenyl)-4-methyl-
1-(4-methylbenzenesulfonyl)-1,2,4-triazin-6-ol (3i) The procedure was
1-phenyl-1,2,4-triazin-6-ol (3b) Oil, IR (oil) cmꢂ1: 1610, 1670, 2900— the same as described above, except that phenylhydrazine was replaced with
3550; 1H-NMR (500 MHz, CDCl3) d: 2.86 (s, 3H), 3.34 (d, 1H, Jꢀ12.8), tosylhyrazine: Yield 17%, oil, IR (oil) cmꢂ1: 1610, 1670, 1740, 3450; H-
1
3.65 (d, 1H, Jꢀ12.8), 3.81 (s, 3H), 6.90 (d, 2H, Jꢀ8.9), 7.15 (t, 1H, Jꢀ7.8), NMR (500 MHz, CDCl3) d: 2.43 (s, 3H), 2.81 (s, 3H), 3.38 (dd, 1H, Jꢀ3.1,
7.30 (t, 2H, Jꢀ7.8), 7.41 (d, 2H, Jꢀ7.8), 7.45 (d, 2H, Jꢀ8.9); 13C-NMR
13.4), 3.66 (d, 1H, Jꢀ13.4), 3.82 (s, 3H), 6.87 (d, 2H, Jꢀ8.9), 7.29 (d, 2H,
(125 MHz, CDCl3) d: 40.45 (CH3), 52.41 (CH2), 55.29 (CH3), 79.42 (C, Jꢀ8.9), 7.31 (d, 2H, Jꢀ8.2), 7.91 (d, 2H, Jꢀ8.2); 13C-NMR (125 MHz,
2JCFꢀ30), 113.72 (CH), 123.50 (CF3, 1JCFꢀ291), 125.28 (CH), 125.47 CDCl3) d: 21.60 (CH3), 40.13 (CH3), 51.84 (CH2), 55.30 (CH3), 80.41 (C,
(CH), 126.07 (C), 128.62 (CH), 129.93 (CH), 144.70 (C), 147.13 (C), 2JCFꢀ33), 113.65 (CH), 123.10 (CF3, JCFꢀ291), 124.74 (C), 128.64 (CH),
1
160.38 (C); MS m/z: 365 (Mꢁ, 100). HR-MS Calcd for C18H18F3N3O2: 129.03 (CH), 130.25 (CH), 135.03 (C), 144.21 (C), 148.06 (C), 160.91 (C);